Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis
- Conditions
- First Posted Date
- 2012-05-07
- Last Posted Date
- 2012-05-07
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 267
- Registration Number
- NCT01592084
- Locations
- 🇺🇸
the Methodist Neurological Institute, Houston, Texas, United States
Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT)
- Conditions
- Interventions
- First Posted Date
- 2011-10-04
- Last Posted Date
- 2023-01-23
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 38
- Registration Number
- NCT01446016
- Locations
- 🇺🇸
Houston Methodist Hospital Sugar Land, Sugar Land, Texas, United States
🇺🇸Houston Methodist Hospital Cancer Center, Houston, Texas, United States
🇺🇸Houston Methodist Hospital Willowbrook, Houston, Texas, United States
A Trial of Esophageal and Gastric Stenting for Leak or Perforation
- Conditions
- Interventions
- First Posted Date
- 2010-04-20
- Last Posted Date
- 2016-03-17
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 10
- Registration Number
- NCT01107249
- Locations
- 🇺🇸
The Methodist Hospital, Houston, Texas, United States
Neo-Adjuvant Study in Triple Negative Breast Cancer Patients
- First Posted Date
- 2010-04-01
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 40
- Registration Number
- NCT01097642
- Locations
- 🇺🇸
The Methodist Hospital Cancer Center, Houston, Texas, United States
Safety of Riluzole in Patients With Acute Spinal Cord Injury
- Conditions
- First Posted Date
- 2009-04-07
- Last Posted Date
- 2017-09-12
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 36
- Registration Number
- NCT00876889
- Locations
- 🇺🇸
The University of Texas, Houston, Texas, United States
🇺🇸University of Virginia Health System, Charlottesville, Virginia, United States
🇺🇸University of Louisville Health Sciences Center, Louisville, Kentucky, United States
Adrenal Insufficiency in Septic Shock
- First Posted Date
- 2009-02-12
- Last Posted Date
- 2011-06-29
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 32
- Registration Number
- NCT00842933
- Locations
- 🇺🇸
The Methodist Hospital, Houston, Texas, United States
Relapsed and/or Refractory Non-Hodgkin Lymphoma Study
- Conditions
- Interventions
- First Posted Date
- 2009-02-05
- Last Posted Date
- 2017-09-19
- Lead Sponsor
- The Methodist Hospital Research Institute
- Registration Number
- NCT00837174
Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC
- Conditions
- Interventions
- First Posted Date
- 2007-08-29
- Last Posted Date
- 2016-03-17
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 10
- Registration Number
- NCT00522249
- Locations
- 🇺🇸
Baylor College of Medicine - Methodist Hospital, Houston, Texas, United States
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2007-08-28
- Last Posted Date
- 2016-03-17
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 14
- Registration Number
- NCT00521781
- Locations
- 🇺🇸
Baylor College of Medicine - Methodist Hospital, Houston, Texas, United States
Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer
- First Posted Date
- 2007-08-27
- Last Posted Date
- 2016-03-17
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 11
- Registration Number
- NCT00521274
- Locations
- 🇺🇸
Baylor College of Medicine - Methodist Hospital, Houston, Texas, United States